2024
Clinical, immunophenotypic, and genomic findings of acute myeloid leukemia with RAM immunophenotype: Comparison with other CD56‐positive acute leukemias
Hamdan H, Liu Y, Wang S, Bledsoe J, Chisholm K, Siddon A, Ohgami R, George T, Kurzer J, Hasserjian R, Arber D, Bagg A, Foucar K, Margolskee E, Laczko D, Chen W, Fuda F, Aggarwal N, Weinberg O. Clinical, immunophenotypic, and genomic findings of acute myeloid leukemia with RAM immunophenotype: Comparison with other CD56‐positive acute leukemias. EJHaem 2024 DOI: 10.1002/jha2.1052.Peer-Reviewed Original ResearchAcute myeloid leukemiaAcute undifferentiated leukemiaExpression of CD56Children's Oncology GroupAcute leukemiaRAM immunophenotypeBlast percentageHLA-DRMyeloid leukemiaT-ALLBone marrowBright expressionFrequency of abnormal karyotypesWeak to absent expressionCharacteristics of acute myeloid leukemiaAcute myeloid leukemia groupAcute myeloid leukemia casesBCL6 co-repressorBM blast percentageWhite blood cell countAcute leukemia casesClinical differential diagnosisControl groupClinical outcome analysisNext-generation sequencing profiling
2018
Modified approach to fibrinogen replacement in the setting of dysfibrinogenaemia
Chandler JB, Siddon AJ, Bahel P, Torres R, Rinder HM, Tormey CA. Modified approach to fibrinogen replacement in the setting of dysfibrinogenaemia. Journal Of Clinical Pathology 2018, 72: 177. PMID: 30463936, DOI: 10.1136/jclinpath-2018-205438.Peer-Reviewed Original Research